CAM
Cormorant Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-300,000
| Closed | -$8.08M | – | 60 |
|
2024
Q1 | $8.08M | Sell |
300,000
-150,000
| -33% | -$4.04M | 0.35% | 47 |
|
2023
Q4 | $13.5M | Hold |
450,000
| – | – | 0.64% | 36 |
|
2023
Q3 | $9.22M | Sell |
450,000
-418,550
| -48% | -$8.58M | 0.54% | 36 |
|
2023
Q2 | $17.3M | Hold |
868,550
| – | – | 0.97% | 28 |
|
2023
Q1 | $14.9M | Hold |
868,550
| – | – | 0.98% | 29 |
|
2022
Q4 | $17M | Hold |
868,550
| – | – | 1.14% | 30 |
|
2022
Q3 | $13.9M | Hold |
868,550
| – | – | 0.97% | 37 |
|
2022
Q2 | $12M | Hold |
868,550
| – | – | 0.9% | 35 |
|
2022
Q1 | $13.8M | Hold |
868,550
| – | – | 1.06% | 28 |
|
2021
Q4 | $19M | Sell |
868,550
-100,000
| -10% | -$2.18M | 1.13% | 26 |
|
2021
Q3 | $29M | Hold |
968,550
| – | – | 1.18% | 26 |
|
2021
Q2 | $42.9M | Sell |
968,550
-400,000
| -29% | -$17.7M | 1.46% | 21 |
|
2021
Q1 | $60.7M | Hold |
1,368,550
| – | – | 1.35% | 14 |
|
2020
Q4 | $75.1M | Hold |
1,368,550
| – | – | 1.79% | 14 |
|
2020
Q3 | $31.3M | Sell |
1,368,550
-100,000
| -7% | -$2.29M | 1.2% | 26 |
|
2020
Q2 | $30.7M | Sell |
1,468,550
-100,000
| -6% | -$2.09M | 1.17% | 23 |
|
2020
Q1 | $21.9M | Sell |
1,568,550
-268,719
| -15% | -$3.75M | 1.02% | 26 |
|
2019
Q4 | $41.8M | Sell |
1,837,269
-286,491
| -13% | -$6.52M | 1.67% | 17 |
|
2019
Q3 | $24.7M | Buy |
2,123,760
+49,165
| +2% | +$573K | 1.51% | 19 |
|
2019
Q2 | $31.1M | Buy |
2,074,595
+374,595
| +22% | +$5.62M | 1.79% | 18 |
|
2019
Q1 | $29.8M | Sell |
1,700,000
-245,659
| -13% | -$4.31M | 2.02% | 20 |
|
2018
Q4 | $28.8M | Buy |
1,945,659
+445,000
| +30% | +$6.59M | 2.34% | 13 |
|
2018
Q3 | $36.9M | Sell |
1,500,659
-19,231
| -1% | -$473K | 2.4% | 13 |
|
2018
Q2 | $29.8M | Sell |
1,519,890
-1
| -0% | -$20 | 2.21% | 14 |
|
2018
Q1 | $28.5M | Buy |
+1,519,891
| New | +$28.5M | 2.12% | 11 |
|